2020
DOI: 10.1089/wound.2019.1051
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
45
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 34 publications
(47 citation statements)
references
References 71 publications
1
45
1
Order By: Relevance
“…In our previous work [ 26 ], we optimized a procedure to use fibroblasts, keratinocytes, and ASCs as models in skin regeneration studies. We used serum free culture media, because addition of FBS, which contains various growth factors, which stimulate cell proliferation or migration, could mask IM’s effect.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…In our previous work [ 26 ], we optimized a procedure to use fibroblasts, keratinocytes, and ASCs as models in skin regeneration studies. We used serum free culture media, because addition of FBS, which contains various growth factors, which stimulate cell proliferation or migration, could mask IM’s effect.…”
Section: Discussionmentioning
confidence: 99%
“…We also assessed the allergic potential of IM peptide, using an in vitro method, namely the BAT described previously [ 26 ]. The conducted tests showed low allergic potential of IM peptide, thus confirming the immunological safety of this peptide.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations